Nakao and his associates have demonstrated that when blood, which had previously been stored at 40 C for 8 to 10 weeks in acid-citratedextrose (ACD), was subsequently incubated at 370 C with both adenine and inosine, regeneration of ATP and restoration of post-transfusion viability took place (1-3). ATP regeneration did not occur when the incubation medium contained either adenine or inosine alone. Moreover, supplementation of the ACD preservative with both adenine and inosine at the beginning of storage resulted in better maintenance of ATP and posttransfusion viability than in samples stored with inosine alone or not supplemented at all (3-5).
370 C with both adenine and inosine, regeneration of ATP and restoration of post-transfusion viability took place (1) (2) (3) . ATP regeneration did not occur when the incubation medium contained either adenine or inosine alone. Moreover, supplementation of the ACD preservative with both adenine and inosine at the beginning of storage resulted in better maintenance of ATP and posttransfusion viability than in samples stored with inosine alone or not supplemented at all (3) (4) (5) .
Although these studies indicated that both inosine and adenine were necessary for rejuvenation of long-stored erythrocytes, it seemed possible that adenine could act without inosine in preventing loss of red cell viability when it was present from the beginning of storage, since at that time, unlike later in storage, glucose utilization for energy production is still intact. Moreover, eliminating inosine would have the further advantage of avoiding toxicity from uric acid overload in the recipient. Accordingly, we investigated the effect of supplementing the ACD preservative with adenine alone from the beginning of storage and showed that small amounts of adenine, without nucleoside, preserve satisfactory viability of stored erythrocytes for at least 5 weeks. Adenine also maintained higher ATP levels throughout the 6-week storage period and better preservation of erythrocyte glycolytic capacity, measured at the end of the storage period, than in control cells kept in ACD. Gluose consumption and lactate formation throughout the storage period were little affected with optimal adenine supplements despite the maintenance of higher ATP levels (6, 7) .
The present studies were undertaken to elucidate the mechanisms whereby these effects were achieved. The influence of adenine supplementation after 2 weeks of refrigerated storage was also investigated to determine whether such delayed addition would be as effective, or perhaps even more effective, in maintaining adenine nucleotide concentrations, than supplementation at the outset. Methods vol)]. Likewise, in our radiochromatography, more than 99.7% of the radioactivity was associated with the adenine peak [isobutyric acid: 1 M NH40H: 0.1 M disodium EDTA (100: 60: 1.6)]. The adenine supplements were prepared in 0.15 M NaC1 as follows: For the addition of trace amounts, adenine-8-C14 was dissolved to a concentration of 0.5 Amole and 0.75 ,uc per ml (experiment 1) and 0.78 umole and 2.5 /Ac per ml (experiment 2). For larger supplements, adenine-8-C14 and carrier adenine sulfate were dissolved to a final adenine concentration of 20 Amoles and 1 ,uc per ml (experiment 1); the corresponding values for experiment 2 were 20,moles and 3.5 /Ac per ml. For experiments 3 and 4, solutions of adenine sulfate containing 20 gmoles per ml were used. The solutions were sterilized through Millipore 8 filters, and their concentration of adenine was calculated as described previously (6) .
Design of experiments. For experiments 1 and 2, 480 ml of blood from healthy donors was drawn into plastic bags containing 72 ml of ACD (National Institutes of Health, formula A) and each unit divided into three smaller bags.9 Immediately thereafter, one bag was supplemented with a trace amount of adenine-C" to give a final adenine concentration of 0.02 ,umole per ml ACDblood, and another received 0.6 ,umole adenine-C" per ml ACD-blood. The third bag was supplemented with 0.6 ,tmole adenine-C" per ml ACD-blood after 2 weeks of storage. The blood-filled bags were stored at 40 C and portions removed for analysis at intervals up to 6 weeks. Experiments 3 and 4 were similar except that nonradioactive adenine supplements were used. Experiments 1 and 2 were studied consecutively, 3 and 4 concurrently.
Separation of nucleotides, nucleosides, purines, and 2,3-diphosphoglycerate (2,3-DPG). Sixteen-ml samples of whole blood and 8-ml portions of plasma were extracted with 2 vol of cold 0.6 N perchloric acid (PCA) and centrifuged at 40 C. The precipitates were re-extracted once with 15 ml 0.6 N PCA. The combined supernatant solutions were brought to pH 9 with 20%o KOH, centrifuged to remove the precipitated salt, and then applied to Dowex-1-formate columns, 1 X 16 cm. Unknown ultraviolet absorbing materials and adenosine, if any, were eluted with 100 ml of water. Next, adenine, inosine, hypoxanthine, and xanthine were eluted but not resolved with 300 ml 0.005 N formic acid. Uric acid was eluted with 250 ml of 0.05 N formic acid. After the removal of these purines, nucleosides, and uric acid, the separation of nucleotides and 2,3-DPG was carried out with gradually increasing concentrations of formate as described by Hurlbert, Schmitz, Brumm, and Potter (8) . The water eluates from the Dowex-1-formate columns were applied to AG-50W-H+ columns, 0.9 X 12 cm, washed with 100 ml of 0.1 N HCl, and eluted with 200 ml of 0.5 N HCl to recover adenosine, if any. To separate the purines and inosine, the 0.005 N formic acid 8 Millipore Filter Corp, Bedford, Mass. 9 Lot no. FS 0555B, Cutter Laboratories, Berkeley, Calif.
eluates were also applied to AG-50W-H+ columns, and xanthine and inosine, if any, were eluted with 100 ml of 0.1 N HCl, hypoxanthine with 200 ml of 0.3 N HCl, and adenine with 250 ml of 0.8 N HCl. The xanthine and inosine eluates were evaporated to dryness to remove HCl, redissolved in 10 ml of distilled water, and separated on Dowex-1-formate columns with 250 ml of 0.005 N formic acid. The Dowex-1-formate columns were eluted at 40 ml per hour, the AG-50W-H+ columns at 150 ml per hour. The eluates from each column were collected in 10-ml fractions, and the optical density of each fraction was measured at 260 mg with a Beckman model DU spectrophotometer. In addition, fractions eluted with water or 0.005 N formic acid from Dowex-1-formate columns and all eluates from AG-50-H+ columns were read at 250 m,. The peaks were identified from their ultraviolet absorbing spectra (9) by a Beckman model DK spectrophotometer and by their phosphate (10) and ribose (11) Specific radioactivity was calculated from the radioactivity and absorbancy of fractions representing the ultraviolet absorbing peaks.
Other methods. Pyruvate was estimated enzymatically with lactic dehydrogenase (15) . Glucose, lactate, hemoglobin, hematocrit, and pH were measured as described previously (6) .
10We found that a 1: 1 PCA filtrate, prepared as described in the directions, led to incomplete extraction of the ATP. A detailed evaluation of this method is in preparation (13) . * ACD = acid-citrate-dextrose; Ad = adenine; ATP, ADP, and AMP = adenosine tri-, di-, and monophosphate; IMP = inosine monophosphate; Hx = hypoxanthine; AX = unknown adenine-containing compound (see Results). The hemoglobin concentration was 12.5 g per 100 ml in experiment 1 and 11.0 g per 100 ml in experiment 2.
Results
In the experiments to be described, radioactive adenine (0.6 Mmole per ml) was added to ACDblood either at the beginning or after 2 weeks of refrigerated storage and its effect on purine metabolism and glycolysis throughout a 6-week storage period compared with ACD-blood controls, containing adenine-C14 in trace amounts (0.02 /Amole per ml).
The quantitative results are given in Tables I  and II . Since the results of experiments 1 and 2 were similar, only experiment 2 was selected for graphic presentation. Table I ). In samples supplemented at the beginning of storage, the ATP concentrations increased during the first 1 to 2 weeks reaching maximal values that were 10 and 14% higher than at the outset. Thereafter the ATP concentrations slowly declined so that by 6 weeks 70 and 79% of the initial ATP concentration were preserved compared with 32 and 43% for the ACD controls. Adenine supplementation after 2 weeks of storage also resulted in an initial increase in ATP followed by a decline; by 6 weeks, 57 and 70% of the initial ATP concentration remained.
In a second study of similar design 2 additional U of blood were collected, subdivided, portions supplemented with adenine, and stored at 40 C (experiments 3 and 4). In the adenine- In addition to its influence on ATP, adenine also resulted in the maintenance of higher ADP and adenosine monophosphate (AMP) levels throughout the storage period ( Figure 1 and Table I ); supplementation at the outset was slightly more effective in this respect than was addition after 2 weeks. In all the samples, the levels of AMP increased up to 4 weeks of storage and then remained unchanged. The behavior of ADP was slightly more variable. In experiment 1, adenine supplementation, either at the beginning or after 2 weeks of storage, led to a rapid increase in ADP with a slight decline after 4 weeks. In experiment 2, ADP increased in all samples (more with adenine) reaching a maximum after about 4 weeks, and then declined.
The effect of adenine on total adenine nucleotide levels (AMP, ADP, and ATP) is illustrated in Figure 3 . With supplementation from the beginning maximal adenine nucleotide concentrations were achieved within 1 to 2 weeks that were 22 and 27%o higher than at the outset of storage. By 6 weeks, 88 and 97%o of the initial total adenine nucleotide concentration were preserved with initial adenine supplementation, and 74 and 87%o were preserved when it was delayed 2 weeks, compared with 43 and 53%o for the controls containing adenine-C'4 tracer.
During the first 2 weeks of storage, hypoxanthine accumulated only in the adenine-supplemented samples; thereafter, its rate of accumulation increased, was approximately linear with time, and was not influenced by the presence of adenine. In the ACD controls with adenine-C'4 tracer, hypoxanthine was present in small amounts 30 40 11 This figure seems at variance with the remainder of on the first day of storage but was not detected in the day 16 samples.
In the ACD controls with adenine-C14 tracer, inosine monophosphate (IMP) had reached its maximal concentration by 2 weeks of storage. By contrast, with substrate amounts of adenine present from the beginning, the rate of increase in IMP was more gradual and reached only about one-half the concentration found in the controls. Adenine supplementation after 2 weeks of storage led to a decrease in IMP so that by 6 weeks IMP levels were slightly lower than those obtained with adenine supplementation from the beginning.
B) Specific radioactivity of purine compounds.
The specific radioactivity data for experiment 2 are plotted in Figure 4 ; the total radioactivity recovered in the purine compounds (per gram of hemoglobin) for both experiments is given in Table II .
After the addition of adenine-C14 the specific radioactivity of AMP at first exceeded that of ADP and ATP (Figure 4) . Subsequently, the specific activities of the three adenine nucleotides in each blood sample were similar to each other. trast, in control samples containing only trace quantities of adenine (0.02 jumole) they decreased A slightly after 2 weeks of storage. This was more pronounced in experiment 2 and may be due, in part, to an unexplained progressive decline in the total radioactivity recovery in this control sample (Table II) . With initial adenine supplementation the specific activities of hypoxanthine were similar to those of AMP on the first day of storage; thereafter the hypoxanthine and adenine nucleotide specific radioactivities were approximately the same. With supplementation later in storage (when hypoxanthine accumulation had already begun) the hypoxanthine specific activities were A usually less than those of the adenine nucleotides.
With supplementation of substrate amounts of adenine-C14, the IMP specific activities were lower than those of the other compounds. This in higher concentrations within the cells. On the assumption that 70% of the cell volume and 93% of the plasma are water, the intracellular concentration of adenine averaged 1.8 times that of plasma; the corresponding figure for hypoxanthine was 1.5. These ratios were independent of the duration of storage. The specific activities of adenine and hypoxanthine were approximately the same inside and outside the cells. Adenine was not detected in the ACD control samples supplemented with adenine-C14 tracer after the first day of storage.
II) Glycolysis
Glycolysis was measured by glucose disappearance and lactate formation throughout the storage period. With adenine, glycolysis was slightly lower than in samples kept in ACD alone, as was reported previously (6) . In all samples, 2,3-DPG decreased rapidly and reached the lowest value by the end of 2 weeks. With adenine the rate of decrease was more rapid than in its absence (Figure 5 ). Pyruvate accumulation during the storage period was small.
The pH (measured at room temperature) was 7.12 to 7.20 at the outset of storage and declined to values between 6.74 and 6.79 after 6 weeks. Adenine supplementation did not influence these values, as was previously reported (6).
Discussion
In our previous studies (6, 7), we showed that supplementation of the ACD preservative with small amounts of adenine resulted in better main-tenance of red cell post-transfusion viability and ATP levels throughout a 6-week period of refrigerated storage. The present studies were undertaken to elucidate the mechanisms whereby these effects were achieved.
With adenine supplementation (0.6 /Lmole per ml ACD-blood) at the beginning of storage, the levels of all three adenine nucleotides, ATP, ADP, and AMP, increased up to 2 weeks of storage. In control samples with tracer adenine-C14 (0.02 jumole per ml) the ATP levels decreased steadily, ADP showed little change, and AMP increased but not so much as with substrate adenine. Thereafter, the ATP levels declined in all samples, but the rate of decline was less when adenine was present. Thus, under these conditions the presence of adenine in substrate amounts led to a net synthesis of adenine nucleotides early in storage, achieving levels higher than those present in the fresh blood. Moreover, adenine maintained not only higher ATP levels but also higher adenine nucleotide levels throughout the storage period. As the adenine concentration declined, the concentration and radioactivity of the adenine nucleotides increased, indicating incorporation of adenine into the adenine nucleotides. Although the rate of adenine incorporation was more rapid early in storage, the continued gradual disappearance of adenine and the sustained rise in the adenine nucleotide specific radioactivity indicated that adenine incorporation continued throughout the storage period. These findings support the earlier observations that freshly drawn, as well as stored, human red cells are capable of incorpo- 50 umole tADP per 102 g hemoglobin for day 16 (see Table I ). rating adenine into adenine nucleotides (18, 19) , resulting in net adenine nucleotide synthesis (2, (20) (21) (22) . This continued slow incorporation of adenine into adenine nucleotides, rather than any inhibitory effect of adenine on adenine nucleotide breakdown, appeared responsible for the slower decline of total adenine nucleotides with adenine supplementation (Table III) . Thus, between days 16 and 44 of storage, the rate of hypoxanthine accumulation was similar in all samples (column 3) , and the amount of adenine that disappeared (column 2) approximated the difference in adenine nucleotide decline between samples stored with and without adenine (column 1). There was no breakdown of adenine nucleotides into adenine since the specific radioactivity of adenine remained constant throughout the storage period.
When adenine was added to the ACD-blood after 2 weeks of storage, the changes in nucleotide and purine concentrations and in specific radioactivities were qualitatively similar, but quantitatively less than when fresh blood was supplemented with adenine.
Any mechanism for adenine incorporation into adenine nucleotides by stored red cells must explain 1) the initially higher specific radioactivities of AMP as compared with ADP and ATP, 2) the subsequent similar specific radioactivities of the three adenine nucleotides, 3) the constant specific radioactivity of adenine throughout the storage period, 4) the accumulation of hypoxanthine only in samples supplemented with substrate amounts of adenine during the first 2 weeks of storage, 5) the suppression of the increase in IMP with initial supplementation, and 6) the reduction in IMP concentration when adenine is added after 2 weeks.
The following reactions are consistent with these observations:
Glucose + 2 ADP + 2Pinorgaunic
2 lactate + 2 ATP [4] Hx + PRPP IMP + PP [5] Adenine (Ad) initially reacts with 5-phosphoribosyl-l-pyrophosphate (PRPP) to form AMP and pyrophosphate (PP) via AMP-pyrophosphorylase (20, 23) (step 1). Removal of pyrophosphate via inorganic pyrophosphatase (step 2) would account for the irreversibility of step 1. The increased AMP reacts with ATP via adenylate kinase to form ADP (24, 25) (step 3). Finally, ADP is phosphorylated to ATP via Embden-Meyerhof glycolysis (line 4) . If the amount of PRPP within the red cell is limited and Ad successfully competes with hypoxanthine (Hx) for PRPP with respect to nucleotide formation (step 5), Hx accumulation will begin earlier and IMP accumulation will be reduced when Ad is supplied, as was observed.
An additional mechanism for the incorporation of adenine into adenine nucleotides would involve the formation of adenosine from ribose-l-phosphate and adenine via purine nucleoside phosphorylase.-Adenosine would then be phosphorylated to form AMP with an adenosine kinase. There are several objections to invoking this mechanism. First, although nucleoside phosphorylase activity utilizing adenine (measured in the direction of nucleoside formation) has been demonstrated in beef liver (26) , the substrate specificity of human erythrocytic purine nucleoside phosphorylase (measured in the direction of purine formation) includes inosine and guanosine but apparently not adenosine (27, 28) . Second, even if adenosine were formed, it is unlikely that appreciable quantities would accumulate, since blood contains a very active adenosine deaminase (29, 30) and, in fact, adenosine was not detected at any time in the course of the present experiments. Finally, incubation of human red cells with adenosine-8-C14 failed to produce more labeling in the adenine portion of ATP than did inosine-8-C14 (22) . Nevertheless, red cell viability is better maintained with adenosine than with inosine (3) , and adenosine appears to be more effective than inosine, inosine plus adenine, or adenine alone in maintaining and regenerating ATP in stored or nucleotide-depleted cells (2, (31) (32) (33) (34) (35) (36) (37) (38) . Since adenosine, through deamination, may raise pH and would thus be expected to maintain hexokinase activity (39) , possibly some of the aforementioned effects of adenosine on ATP maintenance and viability may be explained by this means. Until this or some other mechanism of action of adenosine is confirmed, the possibility that adenosine is an intermediate in the mechanism of action of adenine cannot be completely discarded.
Since adenine incorporation results in net adenine nucleotide synthesis and the maintenance of higher adenine nucleotide levels throughout the storage period, more energy for high-energy phosphate bond formation would appear to be required in adenine-supplemented than in control samples. The most obvious energy source is glucose, but in these experiments as well as in the ones previously reported (6), there was slightly less glucose disappearance and lactate formation in the samples supplemented with adenine. The explanation may lie in the utilization of different pathways for glucose breakdown. Thus, 1,3-diphosphoglycerate may be converted to 3-phosphoglycerate either via phosphoglycerate kinase or via 2,3-diphosphoglyceromutase and 2,3-diphosphoglycerate phosphatase-the Rapoport-Luebering cycle (40) . The former reaction provides an energy generating mechanism, the latter reactions a means for excess energy dissipation. If, in the presence of adenine, a greater proportion of 1,3-diphosphoglycerate is metabolized via the phosphoglycerate kinase reaction, an increased yield of high-energy phosphate would be expected without changing glucose utilization or lactate formation. Consistent with this hypothesis are the observations in the adenine-supplemented samples of higher ADP levels ( Figure 1 and Table II) , which would be expected to favor 1,3-diphosphoglycerate metabolism via phosphoglycerate kinase (41) , and the more rapid decline of 2,3-DPG ( Figure 5 ).
These studies also provide some information about the degradative sequences of the purine compounds during the storage period. As indicated above, hypoxanthine accumulated only in the adenine-supplemented samples during the first 2 weeks of storage. Its specific activity 24 hours after adenine addition was similar to that of AMP but higher than that of ATP, ADP, or IMP. Subsequently, the specific radioactivities of the three adenine nucleotides and of hypoxanthine were similar but higher than the specific radioactivities of IMP. This suggests that a major route of AMP degradation does not pass through IMP, in contrast to previous reports (16, 18) . Rather, AMP may be hydrolyzed to adenosine (42) , then deaminated to inosine (29, 30, 43, 44) , which finally undergoes phosphorolysis to hypoxanthine (27, 28, 45, 46) . Some of the hypoxanthine may then be incorporated into IMP (16, 18) (step 5), but the specific radioactivity of the IMP will be lower than that of the other compounds due to dilution with the unlabeled IMP present at the beginning of storage (Table I) or before labeled adenine appears as labeled hypoxanthine (Figure 4) .
With adenine supplementation later in storage, the reduction in IMP concentration (Figure 1 ) and the lowered specific radioactivities of hypoxanthine in relation to the specific radioactivities of the adenine nucleotides (Figure 4 ) suggest that IMP gives rise to hypoxanthine, probably by hydrolysis to inosine followed by phosphorolysis.
Neither adenosine nor inosine was detected during the storage period. Thus, the rate determining steps would appear to be the hydrolysis of AMP and IMP. Since xanthine oxidase is missing from human blood (47), the uric acid did not become radioactive, nor did its concentration change during the storage period.
In the control samples containing trace quantities of adenine, the specific radioactivities of the adenine nucleotides decreased slightly after 2 weeks of storage (Figure 4 ). This suggests that the adenine moiety of the nucleotides may be supplied from sources other than radioactive adenine. The synthesis of adenine from simpler units by stored blood appears most unlikely (22) , and interconversion of guanine nucleotides to adenine nucleotides appears limited as well (22) . In the present experiments, the adenine nucleotide fractions that are eluted from the columns just after ATP (48) (49) (50) (51) (52) and that identified as adenylyl-2, 3 diphosphoglyceric acid (53, 54) contained practically no radioactivity, and their concentrations decreased with time. It is possible that these as well as other unknown purine compounds present in small amounts entered the pool of adenine nucleotides and thus diluted their specific radioactivities. The specific radioactivity decline in experiment 2 was more marked than in experiment 1 (Figure 4) , which, as was previously noted, may be due to an unexplained progressive decline in the total radioactivity recovery in this control sample (Table II) .
The present studies support our previous observations (6) that red cells stored with small supplements of adenine (0.5 to 1.0 ttmole per ml ACD-blood) contain more ATP after 6 weeks of refrigerated storage than do control samples stored without adenine. Recently, the effectiveness of adenine supplementation (0.6 ,umole per ml) in maintaining higher ATP and adenine nucleotide levels was confirmed by Bishop, using 48- we have measured ATP after 6 weeks of refrigerated storage with and without 0.5 to 1.0 ptmole of adenine (as adenine sulfate) in 23 U of blood. Higher ATP levels in the adenine-supplemented samples were uniformly observed. The reason for the discrepant-results among these studies is not evident. The concentration of adenine and the conditions of storage appear similar. An apparently minor technical difference involved the use by Shafer and Trombold of adenine that was prepared in ACD and autoclaved, whereas in our studies, the adenine sulfate was dissolved in 0.15 M NaCl and sterilized by filtration. This does not seem a likely explanation for the different results. Ferber and Fischer do not specify precisely how their adenine was prepared.
Our studies may permit the speculation that if means could be found to sustain the initial rapid rate of adenine incorporation, higher adenine nucleotide levels throughout the storage period could be maintained and the period of satisfactory preservation perhaps extended. Several studies have recently appeared that provide promising leads for further exploration. Beutler and Duron have shown that although the optimal pH of the ACD preservative was 5.0 with respect to ATP maintenance during storage at 40 , with adenine present in the preservative mixture, the pH optimum was 5.5 (56) . De Verdier, HMgman, Garby, and Killander have made a similar observation (59) . Supplying inorganic phosphate may also produce higher ATP levels when adenine is present (60) . Thus it appears likely that supplementing phosphate containing preservatives of a slightly higher pH (59, (61) (62) (63) (64) with adenine will give results superior to those obtained with the ACD-adenine solution used in the present study.
Finally, we must emphasize that although higher ATP or adenine nucleotide levels are associated with better post-transfusion survival under these conditions of storage (3) (4) (5) (6) 57) , it is premature to speculate regarding a specific level of adenine nucleotides required to give a certain per cent post-transfusion survival. There are several reasons for this: 1) factors other than the adenine nucleotide level may be of critical importance, especially if the conditions of storage are altered; 2) there remains too much interlaboratory variation both in the measurement of adenine nucleotides and of post-tranfusion survival; and, perhaps most important, 3) adenine nucleotide levels (or any other in vitro measurement) obtained after a period of storage reflect a composite both of cells that are destined for very rapid removal from the circulation and of those that survive normally or nearly so. Until methods are developed that allow separation of such nonviable from viable cells before transfusion, a quantitative relationship between intracellular adenine nucleotide levels and per cent post-transfusion survival can have only limited significance. Summary Adenine-C14 (0.6 umole per ml) was added to acid-citrate-dextrose-blood at the outset or after 2 weeks of refrigerated storage, and its effect on the concentration and specific radioactivity of purines and purine nucleotides was determined throughout a 6-week storage period. With supplementation at the outset, the initial adenine concentration decreased rapidly at first, then more slowly, so that by 6 weeks, about one-half of the initial adenine remained. The adenine was incorporated into adenine nucleotides, resulting in net adenine nucleotide synthesis and values of adenosine triphosphate and of total adenine nucleotides that were about 12 and 25%o higher, respectively, after 1 to 2 weeks of storage than at the outset. Thereafter, the total adenine nucleotide concentrations declined but more gradually than in the acid-citrate-dextrose controls. This slower decline could be accounted for by continued incorporation of adenine into nucleotide rather than by inhibition of nucleotide breakdown. Adenine supplementation after 2 weeks of storage was less effective in maintaining adenine nucleotide levels than was supplementation at the outset. The data support the following hypotheses: 1) adenine is first incorporated into adenosine monophosphate by reacting, presumably, with 5-phosphoribosyl-l-pyrophosphate, 2) inosine monophosphate is not a major intermediate in the conversion of adenosine monophosphate to hypoxanthine, and 3) no adenine is formed in blood during refrigerated storage.
